These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 30925913)
1. Autophagy inhibition enhances PD-L1 expression in gastric cancer. Wang X; Wu WKK; Gao J; Li Z; Dong B; Lin X; Li Y; Li Y; Gong J; Qi C; Peng Z; Yu J; Shen L J Exp Clin Cancer Res; 2019 Mar; 38(1):140. PubMed ID: 30925913 [TBL] [Abstract][Full Text] [Related]
2. [Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis]. Huang J; Sun R; Qi X; Liu L; Yang Y; Sun B Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1091-1096. PubMed ID: 31657331 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-κB is required for oleanolic acid to downregulate PD-L1 by promoting DNA demethylation in gastric cancer cells. Lu X; Li Y; Yang W; Tao M; Dai Y; Xu J; Xu Q J Biochem Mol Toxicol; 2021 Jan; 35(1):e22621. PubMed ID: 32894642 [TBL] [Abstract][Full Text] [Related]
4. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer. Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901 [TBL] [Abstract][Full Text] [Related]
5. MiR-940 promotes the proliferation and migration of gastric cancer cells through up-regulation of programmed death ligand-1 expression. Fan Y; Che X; Hou K; Zhang M; Wen T; Qu X; Liu Y Exp Cell Res; 2018 Dec; 373(1-2):180-187. PubMed ID: 30367831 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer. Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597 [TBL] [Abstract][Full Text] [Related]
7. LPS promotes the expression of PD-L1 in gastric cancer cells through NF-κB activation. Li H; Xia JQ; Zhu FS; Xi ZH; Pan CY; Gu LM; Tian YZ J Cell Biochem; 2018 Dec; 119(12):9997-10004. PubMed ID: 30145830 [TBL] [Abstract][Full Text] [Related]
8. PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression. Wu L; Cai S; Deng Y; Zhang Z; Zhou X; Su Y; Xu D Int Immunopharmacol; 2021 May; 94():107443. PubMed ID: 33581579 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy. Li J; Chen L; Xiong Y; Zheng X; Xie Q; Zhou Q; Shi L; Wu C; Jiang J; Wang H Cell Physiol Biochem; 2017; 41(3):907-920. PubMed ID: 28222426 [TBL] [Abstract][Full Text] [Related]
10. EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions. Sasaki S; Nishikawa J; Sakai K; Iizasa H; Yoshiyama H; Yanagihara M; Shuto T; Shimokuri K; Kanda T; Suehiro Y; Yamasaki T; Sakaida I Gastric Cancer; 2019 May; 22(3):486-496. PubMed ID: 30264329 [TBL] [Abstract][Full Text] [Related]
11. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells. Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036 [TBL] [Abstract][Full Text] [Related]
12. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569 [TBL] [Abstract][Full Text] [Related]
13. MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection. Zheng X; Dong L; Wang K; Zou H; Zhao S; Wang Y; Wang G Ann Surg Oncol; 2019 Mar; 26(3):884-893. PubMed ID: 30565043 [TBL] [Abstract][Full Text] [Related]
14. Relationship between the expressions of PD-L1 and tumour-associated fibroblasts in gastric cancer. Mu L; Yu W; Su H; Lin Y; Sui W; Yu X; Qin C Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1036-1042. PubMed ID: 30983436 [TBL] [Abstract][Full Text] [Related]
15. Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD-L1 axis in gastric cancer. Zhang Q; Yang C; Ma Z; Ye L; Wu Y; Zhong C; Shi Y; Zhu M Mol Carcinog; 2024 Aug; 63(8):1611-1620. PubMed ID: 38780147 [TBL] [Abstract][Full Text] [Related]
16. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis. Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322 [No Abstract] [Full Text] [Related]
17. IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer. Liao H; Chang X; Gao L; Ye C; Qiao Y; Xie L; Lin J; Cai S; Dong H J Transl Med; 2023 Nov; 21(1):828. PubMed ID: 37978543 [TBL] [Abstract][Full Text] [Related]